About Bioatlas
Bioatlas is a company based in Tartu (Estonia) founded in 2006. The company has 6 employees. Bioatlas offers products and services including Atlas ClearSight DNA Stain, Atlas ClearSight Gold DNA Stain, Atlas Taq DNA Polymerase, Titan HotTaq EvaGreen qPCR Mix, and Atlas Agarose Ultra Pure. Bioatlas operates in a competitive market with competitors including Abcam, ArcherDX, Stem Cell Technologies, OriGene and Sangon Biotech, among others.
- Headquarter Tartu, Estonia
- Employees 6
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioatlas.com
- Social LinkedIn
- Legal Name Bioatlas Oü
- Annual Revenue$572.05 K (USD)-4as on Dec 31, 2023
- Net Profit$104.43 K (USD)358as on Dec 31, 2023
- Latest Funding Round$5.15M (USD), Grant
Nov 2018
- InvestorsEuropean Union
& 1 more
- Employee Count6
Products & Services of Bioatlas
Bioatlas offers a comprehensive portfolio of products and services, including Atlas ClearSight DNA Stain, Atlas ClearSight Gold DNA Stain, Atlas Taq DNA Polymerase, Titan HotTaq EvaGreen qPCR Mix, and Atlas Agarose Ultra Pure.
Stain for visualizing DNA in electrophoresis applications
Advanced stain for enhanced DNA detection in gels
Enzyme for efficient PCR amplification processes
Mix for quantitative PCR with real-time detection
Pure agarose for high-resolution gel electrophoresis
Dye for sample loading in DNA electrophoresis
Funding Insights of Bioatlas
- Total Rounds 2
- Last Round Grant — $5.15M
- First Round $1.02M
(Apr 2015)
- Investors Count 2
All 2 funding rounds of Bioatlas with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $5.15M | Grant | – | – | |
| Apr 2015 | $1.02M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Bioatlas
Bioatlas has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Bioatlas
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioatlas
3 dated milestones of Bioatlas across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Bioatlas is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $5.2M.
Competitors of Bioatlas
Bioatlas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, ArcherDX, Stem Cell Technologies, OriGene and Sangon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research |
Detailed competitors of Bioatlas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioatlas
Websites that share an audience with Bioatlas (bioatlas.com).
Websites whose visitors overlap most with Bioatlas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biosupply.co.uk | biosupply.co.uk | 100% | – | – | – |
| ampliqon.com | 98% | – | #5,972,454 | View details | |
ozyme.fr | ozyme.fr | 98% | – | #1,894,501 | – |
lightlabsusa.com | lightlabsusa.com | 98% | – | #3,903,210 | – |
leighlabs.com | leighlabs.com | 98% | – | #12,140,838 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Bioatlas
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Bioatlas
10 companies that operate in the same segment as Bioatlas (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioatlas
Bioatlas was founded in 2006 and raised its 1st funding round 9 years after it was founded.
Bioatlas is headquartered in Tartu, Estonia.
Bioatlas has 6 employees.
Annual revenue of Bioatlas is $572.05K as on Dec 31, 2023.
Bioatlas engages in manufacturing molecular biology reagents. The product portfolio of the company includes DNA dyes, DNA Polymerases, PCR Mixes, qPCR Mixes, PCR Buffers Reagents (Atlas PCR Water, Atlas 25 mM MgCl2, Atlas 10x Taq Buffer, and Atlas 10x Taq Buffer with (NH4)2SO4) , Nucleotides, Electrophoresis (Agarose Loading dyes Ladders), and Ready-Mixed Buffers.
Bioatlas's top competitors include Abcam, Meridian Bioscience and ArcherDX.
Bioatlas offers Atlas ClearSight DNA Stain, Atlas ClearSight Gold DNA Stain, Atlas Taq DNA Polymerase, Titan HotTaq EvaGreen qPCR Mix, and 2 more products and services.
Bioatlas has 2 investors. Key investors include European Union, and EIC Fund.
Bioatlas operates through Bioatlas Oü.